Complete Dose Conversion Guide: Making the Switch Safely
Understanding Mounjaro vs Wegovy Dose Equivalent Conversions
When considering a switch between Mounjaro (tirzepatide) and Wegovy (semaglutide), understanding dose equivalents is essential for maintaining treatment effectiveness. Mounjaro is a dual GIP/GLP-1 receptor agonist, while Wegovy targets GLP-1 receptors only, making direct dose conversions complex and requiring individual assessment. Generally, patients switching from Mounjaro 2.5mg may transition to Wegovy 0.5mg, whilst those on Mounjaro 15mg might move to Wegovy 2.4mg, though your prescriber will determine the most appropriate starting dose. The conversion isn't simply mathematical — factors including your response to current treatment, side effect tolerance, and weight management progress all influence the decision.
Both prescription-only medicines require careful titration, with Wegovy following a structured escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance. This systematic approach ensures optimal tolerance regardless of your previous Mounjaro experience. Your EverydayMeds prescriber will evaluate your current dose, treatment duration, and response before recommending the most suitable Wegovy starting point. Remember, switching between these medications should never be attempted without professional guidance — the dose equivalent calculation must account for individual patient factors beyond simple milligram comparisons.
Switch & Save: Mounjaro vs Wegovy Dose Equivalent Pricing
Cost considerations often drive patients to explore Mounjaro vs Wegovy dose equivalent options, and Wegovy may offer significant savings depending on your current treatment costs. Our Wegovy pricing starts at £79.99 for the 0.25mg starter dose (after FIRST40 discount for new customers), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. For returning customers, code DOSE25 applies these same final prices at checkout. Our Getting Started bundles provide additional convenience — the Intro Duo (0.25mg & 0.5mg) costs £169.99, while the Progress Duo (0.5mg & 1mg) is £189.99, ensuring smooth dose escalation.
When comparing your current Mounjaro costs against Wegovy equivalents, consider both the monthly expense and your insurance or private prescription arrangements. Many patients switching from higher Mounjaro doses find substantial monthly savings with Wegovy's 2.4mg maintenance dose at £209.99. Our Consistency bundles offer two identical pens — Consistency 2.4mg (×2) provides two months' maintenance supply for £419.99. The Ultimate Stability Trio delivers three months of 2.4mg maintenance for £649.99, providing supply security alongside potential cost benefits compared to individual monthly prescriptions.
Clinical Evidence Supporting Mounjaro vs Wegovy Dose Equivalent Efficacy
Both Mounjaro and Wegovy demonstrate robust clinical evidence, though direct head-to-head comparisons are limited due to different trial designs and patient populations. The STEP trials showed Wegovy may support average weight reductions of approximately 15% at 68 weeks when used alongside diet and exercise (Wilding et al., NEJM, 2021). STEP 5 demonstrated sustained efficacy with ~15.2% average weight loss maintained at two years, while the SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events.
When considering Mounjaro vs Wegovy dose equivalent switches, patients should understand that individual responses may vary between the dual GIP/GLP-1 mechanism and GLP-1-only targeting. Your prescriber will evaluate your current treatment response, any side effects experienced, and weight management progress to determine whether switching doses or medications might optimise your outcomes. Clinical assessment ensures the transition supports continued progress rather than disrupting successful treatment.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones to support weight management alongside lifestyle modifications. Once weekly, the FlexTouch pen delivers semaglutide subcutaneously, where it binds to GLP-1 receptors in your brain's appetite centres, potentially reducing hunger signals and promoting satiety after smaller meals. This mechanism may help decrease food cravings and extend the feeling of fullness between meals, supporting your reduced-calorie diet efforts. Unlike Mounjaro's dual receptor targeting, Wegovy focuses specifically on GLP-1 pathways, which some patients find more tolerable while maintaining effective appetite regulation. The once-weekly dosing schedule provides consistent therapeutic levels throughout the week, supporting sustainable eating pattern changes essential for long-term weight management success.
Seamless Ordering Process for Your Mounjaro vs Wegovy Switch
Switching from Mounjaro to Wegovy through EverydayMeds involves a straightforward three-step process designed for safety and convenience. Begin with our 3-minute online clinical assessment, detailing your current Mounjaro dose, treatment duration, response, and any side effects experienced — this information guides your prescriber's dose equivalent recommendation. Our UK-registered prescribers (GPhC #9012878) review applications within 3 working days, or 24 hours with express service, ensuring thorough evaluation of your switch request and appropriate Wegovy starting dose selection. Once approved, your prescription-only medicine ships via next-day delivery using cold-chain temperature-controlled packaging, maintaining medication integrity from our pharmacy to your door. This seamless process eliminates treatment gaps while ensuring professional oversight of your medication transition. Having both Mounjaro and Wegovy available from one trusted pharmacy simplifies future prescription management and maintains continuity of care throughout your weight management journey.
Storage and Practical Considerations for Dose Equivalent Switching
Understanding storage requirements becomes particularly important when switching between Mounjaro vs Wegovy dose equivalents, as handling differences may influence your medication choice. Wegovy requires refrigeration at 2-8°C before first use but offers superior travel flexibility with 6 weeks room temperature stability below 30°C once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen design provides easy subcutaneous injection with pre-loaded doses, eliminating measurement errors during your transition period. Dose escalation follows a mandatory 4-week schedule regardless of your previous Mounjaro dose — skipping escalation steps isn't recommended even for experienced patients. This structured approach ensures optimal tolerance as your system adapts to semaglutide's GLP-1-only mechanism versus tirzepatide's dual receptor targeting. Proper injection site rotation between thigh, abdomen, and upper arm helps maintain consistent absorption throughout your dose equivalent transition.
Personalised Switch Strategy: Optimising Your Mounjaro vs Wegovy Transition
Every patient's switch between Mounjaro vs Wegovy dose equivalents requires individualised planning based on current treatment response, tolerability profile, and weight management goals. Patients experiencing gastrointestinal side effects on higher Mounjaro doses might benefit from Wegovy's different receptor profile, whilst those seeking cost optimisation may find equivalent efficacy at lower monthly expenses. Your prescriber evaluates factors including current weight loss velocity, appetite control effectiveness, and any dose-limiting side effects to recommend optimal Wegovy starting doses.
Timing your switch strategically can minimise treatment disruption — many patients transition at natural dose increase points or when experiencing supply challenges with their current medication. EverydayMeds maintains stock of both medications, enabling flexible switching decisions without availability concerns. Our prescribers can coordinate transition timing with your current prescription cycle, ensuring seamless changeover while maintaining therapeutic momentum in your weight management journey.
Start Your Cost-Effective Switch Today
Ready to explore Mounjaro vs Wegovy dose equivalent options with potential cost savings? Use discount code FIRST40 for new customers or DOSE25 for returning patients to access our competitive Wegovy pricing from £79.99. Our clinical team provides expert guidance on dose conversions, ensuring safe transition between these prescription-only medicines while potentially reducing your monthly treatment costs. Visit our weight loss collection to begin your clinical assessment and discover how switching might optimise both your treatment outcomes and budget. With next-day delivery and comprehensive prescriber support, your medication transition can begin within days of approval. Take the first step towards potentially more cost-effective weight management while maintaining the clinical oversight essential for prescription medication switches.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
